Report Detail

Consumer Goods Global Non-prescription Mouthrinse Market Insights, Forecast to 2028

  • RnM4416461
  • |
  • 31 March, 2022
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Consumer Goods

Summary:

Market Analysis and Insights: Global Non-prescription Mouthrinse Market
Due to the COVID-19 pandemic, the global Non-prescription Mouthrinse market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Alcoholic accounting for % of the Non-prescription Mouthrinse global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hypermarket and Supermarket segment is altered to an % CAGR throughout this forecast period.
China Non-prescription Mouthrinse market size is valued at US$ million in 2021, while the US and Europe Non-prescription Mouthrinse are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Non-prescription Mouthrinse landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Non-prescription Mouthrinse include Johnson & Johnson, Sunstar, P&G, Lion, Colgate-Palmolive, Unilever, Church & Dwight, PIERAS CO and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Alcoholic
Non-alcoholic
Segment by Application
Hypermarket and Supermarket
Convenience Stores
Online Sale
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Non-prescription Mouthrinse market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Johnson & Johnson
Sunstar
P&G
Lion
Colgate-Palmolive
Unilever
Church & Dwight
PIERAS CO
GSK
Caldwell Consumer Health
Weleda
Dentyl Active
Kao Corporation
NYSCPS
WEIMEIZI (GUANGDONG) CO.
Frequently Asked Questions
Which is the most lucrative product segment in the Non-prescription Mouthrinse market?
Which are the prominent strategies of the Non-prescription Mouthrinse market players?
Which factors are increasing the competition in the Non-prescription Mouthrinse market?
Which are the recommendations provided by the Non-prescription Mouthrinse industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Non-prescription Mouthrinse market growth?
Which product segment will register the fastest growth rate in the Non-prescription Mouthrinse market?
Which emerging trends will impact the Non-prescription Mouthrinse market growth?
Which are the high-impact rendering factors in the Non-prescription Mouthrinse market?
Which companies will maintain their lead on the Non-prescription Mouthrinse market?


Table of Contents

    1 Study Coverage

    • 1.1 Non-prescription Mouthrinse Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Non-prescription Mouthrinse Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Alcoholic
      • 1.2.3 Non-alcoholic
    • 1.3 Market by Application
      • 1.3.1 Global Non-prescription Mouthrinse Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hypermarket and Supermarket
      • 1.3.3 Convenience Stores
      • 1.3.4 Online Sale
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Non-prescription Mouthrinse Sales Estimates and Forecasts 2017-2028
    • 2.2 Global Non-prescription Mouthrinse Revenue Estimates and Forecasts 2017-2028
    • 2.3 Global Non-prescription Mouthrinse Revenue by Region: 2017 VS 2021 VS 2028
    • 2.4 Global Non-prescription Mouthrinse Sales by Region
      • 2.4.1 Global Non-prescription Mouthrinse Sales by Region (2017-2022)
      • 2.4.2 Global Sales Non-prescription Mouthrinse by Region (2023-2028)
    • 2.5 Global Non-prescription Mouthrinse Revenue by Region
      • 2.5.1 Global Non-prescription Mouthrinse Revenue by Region (2017-2022)
      • 2.5.2 Global Non-prescription Mouthrinse Revenue by Region (2023-2028)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Non-prescription Mouthrinse Sales by Manufacturers
      • 3.1.1 Global Top Non-prescription Mouthrinse Manufacturers by Sales (2017-2022)
      • 3.1.2 Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2017-2022)
      • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-prescription Mouthrinse in 2021
    • 3.2 Global Non-prescription Mouthrinse Revenue by Manufacturers
      • 3.2.1 Global Non-prescription Mouthrinse Revenue by Manufacturers (2017-2022)
      • 3.2.2 Global Non-prescription Mouthrinse Revenue Market Share by Manufacturers (2017-2022)
      • 3.2.3 Global Top 10 and Top 5 Companies by Non-prescription Mouthrinse Revenue in 2021
    • 3.3 Global Non-prescription Mouthrinse Sales Price by Manufacturers (2017-2022)
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Non-prescription Mouthrinse Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Non-prescription Mouthrinse Sales by Type
      • 4.1.1 Global Non-prescription Mouthrinse Historical Sales by Type (2017-2022)
      • 4.1.2 Global Non-prescription Mouthrinse Forecasted Sales by Type (2023-2028)
      • 4.1.3 Global Non-prescription Mouthrinse Sales Market Share by Type (2017-2028)
    • 4.2 Global Non-prescription Mouthrinse Revenue by Type
      • 4.2.1 Global Non-prescription Mouthrinse Historical Revenue by Type (2017-2022)
      • 4.2.2 Global Non-prescription Mouthrinse Forecasted Revenue by Type (2023-2028)
      • 4.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Type (2017-2028)
    • 4.3 Global Non-prescription Mouthrinse Price by Type
      • 4.3.1 Global Non-prescription Mouthrinse Price by Type (2017-2022)
      • 4.3.2 Global Non-prescription Mouthrinse Price Forecast by Type (2023-2028)

    5 Market Size by Application

    • 5.1 Global Non-prescription Mouthrinse Sales by Application
      • 5.1.1 Global Non-prescription Mouthrinse Historical Sales by Application (2017-2022)
      • 5.1.2 Global Non-prescription Mouthrinse Forecasted Sales by Application (2023-2028)
      • 5.1.3 Global Non-prescription Mouthrinse Sales Market Share by Application (2017-2028)
    • 5.2 Global Non-prescription Mouthrinse Revenue by Application
      • 5.2.1 Global Non-prescription Mouthrinse Historical Revenue by Application (2017-2022)
      • 5.2.2 Global Non-prescription Mouthrinse Forecasted Revenue by Application (2023-2028)
      • 5.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Application (2017-2028)
    • 5.3 Global Non-prescription Mouthrinse Price by Application
      • 5.3.1 Global Non-prescription Mouthrinse Price by Application (2017-2022)
      • 5.3.2 Global Non-prescription Mouthrinse Price Forecast by Application (2023-2028)

    6 North America

    • 6.1 North America Non-prescription Mouthrinse Market Size by Type
      • 6.1.1 North America Non-prescription Mouthrinse Sales by Type (2017-2028)
      • 6.1.2 North America Non-prescription Mouthrinse Revenue by Type (2017-2028)
    • 6.2 North America Non-prescription Mouthrinse Market Size by Application
      • 6.2.1 North America Non-prescription Mouthrinse Sales by Application (2017-2028)
      • 6.2.2 North America Non-prescription Mouthrinse Revenue by Application (2017-2028)
    • 6.3 North America Non-prescription Mouthrinse Market Size by Country
      • 6.3.1 North America Non-prescription Mouthrinse Sales by Country (2017-2028)
      • 6.3.2 North America Non-prescription Mouthrinse Revenue by Country (2017-2028)
      • 6.3.3 United States
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Non-prescription Mouthrinse Market Size by Type
      • 7.1.1 Europe Non-prescription Mouthrinse Sales by Type (2017-2028)
      • 7.1.2 Europe Non-prescription Mouthrinse Revenue by Type (2017-2028)
    • 7.2 Europe Non-prescription Mouthrinse Market Size by Application
      • 7.2.1 Europe Non-prescription Mouthrinse Sales by Application (2017-2028)
      • 7.2.2 Europe Non-prescription Mouthrinse Revenue by Application (2017-2028)
    • 7.3 Europe Non-prescription Mouthrinse Market Size by Country
      • 7.3.1 Europe Non-prescription Mouthrinse Sales by Country (2017-2028)
      • 7.3.2 Europe Non-prescription Mouthrinse Revenue by Country (2017-2028)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Non-prescription Mouthrinse Market Size by Type
      • 8.1.1 Asia Pacific Non-prescription Mouthrinse Sales by Type (2017-2028)
      • 8.1.2 Asia Pacific Non-prescription Mouthrinse Revenue by Type (2017-2028)
    • 8.2 Asia Pacific Non-prescription Mouthrinse Market Size by Application
      • 8.2.1 Asia Pacific Non-prescription Mouthrinse Sales by Application (2017-2028)
      • 8.2.2 Asia Pacific Non-prescription Mouthrinse Revenue by Application (2017-2028)
    • 8.3 Asia Pacific Non-prescription Mouthrinse Market Size by Region
      • 8.3.1 Asia Pacific Non-prescription Mouthrinse Sales by Region (2017-2028)
      • 8.3.2 Asia Pacific Non-prescription Mouthrinse Revenue by Region (2017-2028)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 China Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America Non-prescription Mouthrinse Market Size by Type
      • 9.1.1 Latin America Non-prescription Mouthrinse Sales by Type (2017-2028)
      • 9.1.2 Latin America Non-prescription Mouthrinse Revenue by Type (2017-2028)
    • 9.2 Latin America Non-prescription Mouthrinse Market Size by Application
      • 9.2.1 Latin America Non-prescription Mouthrinse Sales by Application (2017-2028)
      • 9.2.2 Latin America Non-prescription Mouthrinse Revenue by Application (2017-2028)
    • 9.3 Latin America Non-prescription Mouthrinse Market Size by Country
      • 9.3.1 Latin America Non-prescription Mouthrinse Sales by Country (2017-2028)
      • 9.3.2 Latin America Non-prescription Mouthrinse Revenue by Country (2017-2028)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina
      • 9.3.6 Colombia

    10 Middle East and Africa

    • 10.1 Middle East and Africa Non-prescription Mouthrinse Market Size by Type
      • 10.1.1 Middle East and Africa Non-prescription Mouthrinse Sales by Type (2017-2028)
      • 10.1.2 Middle East and Africa Non-prescription Mouthrinse Revenue by Type (2017-2028)
    • 10.2 Middle East and Africa Non-prescription Mouthrinse Market Size by Application
      • 10.2.1 Middle East and Africa Non-prescription Mouthrinse Sales by Application (2017-2028)
      • 10.2.2 Middle East and Africa Non-prescription Mouthrinse Revenue by Application (2017-2028)
    • 10.3 Middle East and Africa Non-prescription Mouthrinse Market Size by Country
      • 10.3.1 Middle East and Africa Non-prescription Mouthrinse Sales by Country (2017-2028)
      • 10.3.2 Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2017-2028)
      • 10.3.3 Turkey
      • 10.3.4 Saudi Arabia

    11 Company Profiles

    • 11.1 Johnson & Johnson
      • 11.1.1 Johnson & Johnson Corporation Information
      • 11.1.2 Johnson & Johnson Overview
      • 11.1.3 Johnson & Johnson Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.1.4 Johnson & Johnson Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.1.5 Johnson & Johnson Recent Developments
    • 11.2 Sunstar
      • 11.2.1 Sunstar Corporation Information
      • 11.2.2 Sunstar Overview
      • 11.2.3 Sunstar Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.2.4 Sunstar Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.2.5 Sunstar Recent Developments
    • 11.3 P&G
      • 11.3.1 P&G Corporation Information
      • 11.3.2 P&G Overview
      • 11.3.3 P&G Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.3.4 P&G Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.3.5 P&G Recent Developments
    • 11.4 Lion
      • 11.4.1 Lion Corporation Information
      • 11.4.2 Lion Overview
      • 11.4.3 Lion Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.4.4 Lion Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.4.5 Lion Recent Developments
    • 11.5 Colgate-Palmolive
      • 11.5.1 Colgate-Palmolive Corporation Information
      • 11.5.2 Colgate-Palmolive Overview
      • 11.5.3 Colgate-Palmolive Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.5.4 Colgate-Palmolive Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.5.5 Colgate-Palmolive Recent Developments
    • 11.6 Unilever
      • 11.6.1 Unilever Corporation Information
      • 11.6.2 Unilever Overview
      • 11.6.3 Unilever Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.6.4 Unilever Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.6.5 Unilever Recent Developments
    • 11.7 Church & Dwight
      • 11.7.1 Church & Dwight Corporation Information
      • 11.7.2 Church & Dwight Overview
      • 11.7.3 Church & Dwight Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.7.4 Church & Dwight Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.7.5 Church & Dwight Recent Developments
    • 11.8 PIERAS CO
      • 11.8.1 PIERAS CO Corporation Information
      • 11.8.2 PIERAS CO Overview
      • 11.8.3 PIERAS CO Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.8.4 PIERAS CO Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.8.5 PIERAS CO Recent Developments
    • 11.9 GSK
      • 11.9.1 GSK Corporation Information
      • 11.9.2 GSK Overview
      • 11.9.3 GSK Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.9.4 GSK Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.9.5 GSK Recent Developments
    • 11.10 Caldwell Consumer Health
      • 11.10.1 Caldwell Consumer Health Corporation Information
      • 11.10.2 Caldwell Consumer Health Overview
      • 11.10.3 Caldwell Consumer Health Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.10.4 Caldwell Consumer Health Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.10.5 Caldwell Consumer Health Recent Developments
    • 11.11 Weleda
      • 11.11.1 Weleda Corporation Information
      • 11.11.2 Weleda Overview
      • 11.11.3 Weleda Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.11.4 Weleda Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.11.5 Weleda Recent Developments
    • 11.12 Dentyl Active
      • 11.12.1 Dentyl Active Corporation Information
      • 11.12.2 Dentyl Active Overview
      • 11.12.3 Dentyl Active Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.12.4 Dentyl Active Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.12.5 Dentyl Active Recent Developments
    • 11.13 Kao Corporation
      • 11.13.1 Kao Corporation Corporation Information
      • 11.13.2 Kao Corporation Overview
      • 11.13.3 Kao Corporation Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.13.4 Kao Corporation Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.13.5 Kao Corporation Recent Developments
    • 11.14 NYSCPS
      • 11.14.1 NYSCPS Corporation Information
      • 11.14.2 NYSCPS Overview
      • 11.14.3 NYSCPS Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.14.4 NYSCPS Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.14.5 NYSCPS Recent Developments
    • 11.15 WEIMEIZI (GUANGDONG) CO.
      • 11.15.1 WEIMEIZI (GUANGDONG) CO. Corporation Information
      • 11.15.2 WEIMEIZI (GUANGDONG) CO. Overview
      • 11.15.3 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.15.4 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.15.5 WEIMEIZI (GUANGDONG) CO. Recent Developments

    12 Industry Chain and Sales Channels Analysis

    • 12.1 Non-prescription Mouthrinse Industry Chain Analysis
    • 12.2 Non-prescription Mouthrinse Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Non-prescription Mouthrinse Production Mode & Process
    • 12.4 Non-prescription Mouthrinse Sales and Marketing
      • 12.4.1 Non-prescription Mouthrinse Sales Channels
      • 12.4.2 Non-prescription Mouthrinse Distributors
    • 12.5 Non-prescription Mouthrinse Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Non-prescription Mouthrinse Industry Trends
    • 13.2 Non-prescription Mouthrinse Market Drivers
    • 13.3 Non-prescription Mouthrinse Market Challenges
    • 13.4 Non-prescription Mouthrinse Market Restraints

    14 Key Findings in The Global Non-prescription Mouthrinse Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Summary:
      Get latest Market Research Reports on Non-prescription Mouthrinse. Industry analysis & Market Report on Non-prescription Mouthrinse is a syndicated market report, published as Global Non-prescription Mouthrinse Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Non-prescription Mouthrinse market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,279.90
      6,559.80
      3,901.95
      7,803.90
      621,310.50
      1,242,621.00
      363,921.00
      727,842.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report